Purchase Order 36C26326P0263

The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis), awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on February 20, 2026, with an ultimate completion date of February 23, 2026. This contract contains no set-aside designation and represents a sole-source procurement reflecting Edwards Lifesciences LLC's exclusive manufacturing capability for these specialized cardiovascular devices. The award falls within the typical range of Edwards Lifesciences LLC's VA purchase orders, which generally range between $32,500 and $102,000, and supports the VA's mission to provide advanced cardiac care to the veteran population.

This purchase order is part of Edwards Lifesciences LLC's extensive portfolio of awards across the VA healthcare system, totaling over 200 prime federal contracts since 2025. The company also maintains two Indefinite Delivery Contracts with the VA worth $7.45 million combined—a $6.5 million five-year agreement with VISN 21 and a $950,000 five-year agreement with VISN 15—which provide long-term frameworks for the supply of transcatheter heart valves and related cardiovascular devices. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, specializes in advanced cardiovascular medical devices and has established itself as a critical supplier of specialized cardiac equipment supporting the VA's surgical programs across multiple service networks.